AS

Adam Sarjee Sathick

Director Director DIN 02609282
DIN 02609282 First appointment Mar 2006 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2006
Shareholding value Locked Premium profile

About Adam Sarjee Sathick

Adam Sarjee Sathick has 20 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

DIN 02609282
Primary Designation Director
First Appointment 27 Mar 2006
Oldest Company Age 20 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Queen Pharmaceuticals Limited U51397TN2006PLC059303
Director 27 Mar 2006 2006 Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Queen Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Adam Sarjee Sathick

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Adam Sarjee Sathick

Adam Sarjee Sathick has 20 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

Adam Sarjee Sathick is associated with 0 companies as Director.

Adam Sarjee Sathick has expertise in General Business.

Adam Sarjee Sathick has 20 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available